CEO SUMMARY: Standardization of bar code labels is a concept whose time has come. After implementing CLSI standard AUTO12-A, first-mover clinical labs report fewer specimen identification errors, a reduction of costs associated with specimen handling errors, and a boost in lab productivity. Moreover, accrediting bodies such as The Joint Commission and the College of American
Tag: laboratory automation systems
BY NOW, MANY OF YOU HAVE HEARD THE NEWS that Cerner Corporation has acquired Labotix, Inc., the laboratory automation company based in Peterborough, Ontario. That transaction was announced last Monday, March 18.
I consider this deal notable because it is an example of how strange bedfellows will be joining forces as healthcare undergoes a radical transformation
CEO SUMMARY: Laboratory medicine is about to find itself between the two jaws of a powerful vise. One jaw is pending major legislative overhaul of the entire healthcare system, along with dwindling reimbursement as Medicare and Medicaid runs out of money. The other jaw is personalized medicine, companion diagnostics, and expensive molecular testing. As these
CEO SUMMARY: Here’s a prediction that automation of work processes for phlebotomy, specimen collection, and specimen transport may be the next trend. Unfolding developments in the United States are creating a situation parallel to what was seen in Japanese hospital laboratories more than two decades ago—and led to the world’s first automated solutions for clinical
CEO SUMMARY: It’s the final chapter of the “Canadian Invasion” of the U.S. laboratory testing market. In the mid-1990s, both MDS and Dynacare built a sizeable presence in the United States as they both worked to develop joint ventures with hospital laboratories. Dynacare was acquired by LabCorp in 2002. In selling two U.S. lab operations,
CEO SUMMARY: It’s an uphill struggle at LAB-Interlink, based in Omaha, Nebraska. Short of funds, staffed with only a few employees, and urgently seeking capital, the company has so far managed to avoid filing for protection under bankruptcy laws. It is an unwelcome turn of events, since, in past years, LAB-Interlink was considered one of
BANKRUPTCY AMONG VENDORS AND SUPPLIERS in the laboratory industry is an uncommon event. Since it is so rare, that is one less issue about which laboratory directors and pathologists must worry.
However, occasionally there are reminders that it is good management practice to track the financial stability of your laboratory’s primary vendors and suppliers. One such example
CEO SUMMARY: Since 1994, thoughtful lab executives have wrestled with the concept of total automation for their laboratory. Despite concerted marketing efforts by some of the world’s most successful diagnostics manufacturers, only a handful of total laboratory automation (TLA) sites are operating today in the United States. In operation, the economics of TLA failed to
CEO SUMMARY: Cytyc, NeoPath and Neuromedical each tapped the public capital markets during the past 18 months. Now investors expect to see earnings growth and dividends as soon as possible. Clinical laboratories should expect intensified sales and marketing efforts from these three companies as they strive to increase sales.
Probably the most ubiquitous sales representatives visiting
EDITOR’S INTRODUCTION: Last fall, Mark Smythe’s four-part DARK REPORT series about the thirteen “Perilous Parallels” common to commercial laboratory managers provoked widespread response among our clients and readers. We’ve invited him back to address management issues involving laboratory automation and robotics. As an industrial engineer with 35 years experience at some of America’s best-run companies,